Literature DB >> 26468203

Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.

Andrew V Caprariello1, Courtney E Batt2, Ingrid Zippe2, Rita R Romito-DiGiacomo2, Molly Karl3, Robert H Miller4.   

Abstract

During mammalian development, myelin-forming oligodendrocytes are generated and axons ensheathed according to a tightly regulated sequence of events. Excess premyelinating oligodendrocytes are eliminated by apoptosis and the timing of the onset of myelination in any specific CNS region is highly reproducible. Although the developing CNS recovers more effectively than the adult CNS from similar insults, it is unknown whether early loss of oligodendrocyte lineage cells leads to long-term functional deficits. To directly assess whether the loss of oligodendrocytes during early postnatal spinal cord development impacted oligodendrogenesis, myelination, and remyelination, transgenic mouse lines were generated in which a modified caspase-9 molecule allowed spatial and temporal control of the apoptotic pathway specifically in mature, myelin basic protein expressing oligodendrocytes (MBP-iCP9). Activating apoptosis in MBP(+) cells of the developing spinal cord during the first postnatal week inhibited myelination. This inhibition was transient, and the levels of myelination largely returned to normal after 2 weeks. Despite robust developmental plasticity, MBP-iCP9-induced oligodendrocyte apoptosis compromised the rate and extent of adult remyelination. Remyelination failure correlated with a truncated proliferative response of oligodendrocyte progenitor cells, suggesting that depleting the oligodendrocyte pool during critical developmental periods compromises the regenerative response to subsequent demyelinating lesions. SIGNIFICANCE STATEMENT: This manuscript demonstrates that early insults leading to oligodendrocyte apoptosis result in the impairment of recovery from demyelinating diseases in the adult. These studies begin to provide an initial understanding of the potential failure of recovery in insults, such as periventricular leukomalacia and multiple sclerosis.
Copyright © 2015 the authors 0270-6474/15/3514031-11$15.00/0.

Entities:  

Keywords:  development; lysolecithin; myelination; oligodendrocyte

Mesh:

Substances:

Year:  2015        PMID: 26468203      PMCID: PMC4604236          DOI: 10.1523/JNEUROSCI.1706-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

2.  Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.

Authors:  Ajit Singh Dhaunchak; Christopher Becker; Howard Schulman; Omar De Faria; Sathyanath Rajasekharan; Brenda Banwell; David R Colman; Amit Bar-Or
Journal:  Ann Neurol       Date:  2012-04-04       Impact factor: 10.422

Review 3.  Neurobiology of periventricular leukomalacia in the premature infant.

Authors:  J J Volpe
Journal:  Pediatr Res       Date:  2001-11       Impact factor: 3.756

4.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

5.  Microglia and memory: modulation by early-life infection.

Authors:  Lauren L Williamson; Paige W Sholar; Rishi S Mistry; Susan H Smith; Staci D Bilbo
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

6.  Social disadvantage, genetic sensitivity, and children's telomere length.

Authors:  Colter Mitchell; John Hobcraft; Sara S McLanahan; Susan Rutherford Siegel; Arthur Berg; Jeanne Brooks-Gunn; Irwin Garfinkel; Daniel Notterman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

7.  Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling.

Authors:  Jun Cai; Yingchuan Qi; Xuemei Hu; Min Tan; Zijing Liu; Jianshe Zhang; Qun Li; Maike Sander; Mengsheng Qiu
Journal:  Neuron       Date:  2005-01-06       Impact factor: 17.173

8.  Synthetic activation of caspases: artificial death switches.

Authors:  R A MacCorkle; K W Freeman; D M Spencer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.

Authors:  S A Back; N L Luo; N S Borenstein; J M Levine; J J Volpe; H C Kinney
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

10.  A critical period for social experience-dependent oligodendrocyte maturation and myelination.

Authors:  Manabu Makinodan; Kenneth M Rosen; Susumu Ito; Gabriel Corfas
Journal:  Science       Date:  2012-09-14       Impact factor: 47.728

View more
  16 in total

1.  Spatiotemporal Control of CNS Myelination by Oligodendrocyte Programmed Cell Death through the TFEB-PUMA Axis.

Authors:  Lu O Sun; Sara B Mulinyawe; Hannah Y Collins; Adiljan Ibrahim; Qingyun Li; David J Simon; Marc Tessier-Lavigne; Ben A Barres
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

2.  Neurovascular-glymphatic dysfunction and white matter lesions.

Authors:  Behnam Sabayan; Rudi G J Westendorp
Journal:  Geroscience       Date:  2021-04-14       Impact factor: 7.713

Review 3.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

4.  Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder.

Authors:  Jessie Newville; Carlos Fernando Valenzuela; Lu Li; Lauren L Jantzie; Lee Anna Cunningham
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

Review 5.  Neuron-oligodendroglia interactions: Activity-dependent regulation of cellular signaling.

Authors:  Michael A Thornton; Ethan G Hughes
Journal:  Neurosci Lett       Date:  2020-03-16       Impact factor: 3.046

Review 6.  Role of glia in optic nerve.

Authors:  Meysam Yazdankhah; Peng Shang; Sayan Ghosh; Stacey Hose; Haitao Liu; Joseph Weiss; Christopher S Fitting; Imran A Bhutto; J Samuel Zigler; Jiang Qian; José-Alain Sahel; Debasish Sinha; Nadezda A Stepicheva
Journal:  Prog Retin Eye Res       Date:  2020-08-06       Impact factor: 21.198

7.  Rnd3 is necessary for the correct oligodendrocyte differentiation and myelination in the central nervous system.

Authors:  M P Madrigal; B Ballester-Lurbe; O Gómez; J A Moreno-Bravo; E Puelles; S Jurado; J M Garcia-Verdugo; I Pérez-Roger; José Terrado
Journal:  Brain Struct Funct       Date:  2021-11-01       Impact factor: 3.270

Review 8.  Oligodendrocyte ablation as a tool to study demyelinating diseases.

Authors:  Ahdeah Pajoohesh-Ganji; Robert H Miller
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 5.135

9.  Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.

Authors:  Theresa Scholl; Angelika Mühlebner; Gerda Ricken; Victoria Gruber; Anna Fabing; Sharon Samueli; Gudrun Gröppel; Christian Dorfer; Thomas Czech; Johannes A Hainfellner; Avanita S Prabowo; Roy J Reinten; Lisette Hoogendijk; Jasper J Anink; Eleonora Aronica; Martha Feucht
Journal:  Brain Pathol       Date:  2017-02-09       Impact factor: 6.508

Review 10.  Regulation and dysregulation of axon infrastructure by myelinating glia.

Authors:  Simon Pan; Jonah R Chan
Journal:  J Cell Biol       Date:  2017-11-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.